Abiopharma

New Form 8-K - ReShape Lifesciences Inc. Filed: 2025-07-03 AccNo: 0001104659-25-065782 Size: 231 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits